Hal Baseman Chief Operating Officer at Valsource Robert Bradway Chair and Chief Executive Officer at Amgen Rick Bright Director at the Biomedical Advanced Research and Development Authority (BARDA); and Deputy Assistant Secretary in the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services Dario Campana Mrs. Lee Kong Chian Chair in Advanced Cellular Therapy and Professor, Department of Paediatrics, at the National University of Singapore Kenneth C. Frazier Chairman and Chief Executive Officer at Merck Sharp & Dohme Mike Grippo Senior Vice President, Strategy & Corporate at Catalent Pharma Solutions Justin Hanes Lewis J. Ort Professor of Ophthalmology at John Hopkins University Jackie Hunter Chief Executive Officer at BENEVOLENTBIO; and CE of Clinical and Strategic Partnerships at BENEVOLENTAI Richard Johnson President and Chief Executive Officer at the Parenteral Drug Association (PDA) Maik Jornitz President and Chief Executive Officer at G-CON Maria José Alonso Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela Kiran Mazumdar-Shaw Chair and Managing Director, Biocon Rino Rappuoli Chief Scientist and Head, External R&D at Glaxosmithkline Mike Rea Chief Executive Officer, Idea Pharma Melinda Richter Global Head of JLabs at Johnson & Johnson Innovation Luc-Alain Savoy Global Head of Biologics – Life Sciences at SGS James N. Thomas EVP, Global Head of Biotherapeutics and President of US Operations at Just - Evotec Biologics Carlo Toniatti Chief Scientific Officer at IRBM Mike Vandiver Senior Vice President of Biotherapeutic Operations at Just - Evotec Biologics Emma Walmsley Chief Executive Officer at Glaxosmithkline
